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Abstract Optical coherence tomography (OCT) was used to
determine optical properties of pelleted human fibroblasts in
which necrosis or apoptosis had been induced. We analysed
the OCT data, including both the scattering properties of the
medium and the axial point spread function of the OCT
system. The optical attenuation coefficient in necrotic cells
decreased from 2.2±0.3 mm
−1 to 1.3±0.6 mm
−1,w h e r e a s ,i n
the apoptotic cells, an increase to 6.4±1.7 mm
−1 was
observed. The results from cultured cells, as presented in
this study, indicate the ability of OCT to detect and
differentiate between viable, apoptotic, and necrotic cells,
based on their attenuation coefficient. This functional
supplement to high-resolution OCT imaging can be of great
clinical benefit, enabling on-line monitoring of tissues, e.g.




In every multi-cellular organism a delicate balance exists
between cell division, on one hand, and cell death, on the
other hand. Cell death can be executed by two different
pathways, necrosis and apoptosis [1]. Necrosis, the patho-
logical pathway, is also known as accidental cell death,
which is triggered by external disturbances, e.g. physical
trauma, chemical stress or hypoxia. Its morphology is
characterized by slight initial cellular swelling, followed by
cell lysis. In vivo, the resulting cell debris triggers an
inflammatory response.
The physiological pathway of cell death is called
apoptosis, also known as programmed cell death. It is a
general mechanism for the clearance of cells that have
become superfluous or show an aberrant function, without
causing inflammation. The apoptotic pathway is conducted
by a series of tightly regulated biochemical processes in
which a cell, once triggered, goes through consecutive
phases of cell shrinkage, chromatin condensation and
breakdown, nuclear disintegration, cell blebbing and the
formation of so-called apoptotic bodies. These apoptotic
bodies contain nuclear fragments and cell organelles
(Fig. 1). Under normal physiological conditions they are
cleared by either macrophages or neighbouring cells
through phagocytosis [2].
As the physiological counterpart of cell growth, apoptosis
plays an important role in the balance of tissue dynamics.
Disturbances in this balance results in disease. If aberrant
cells do not undergoapoptosis, a tumour can develop. On the
other hand, excessive apoptosis can result in degenerative
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DOI 10.1007/s10103-009-0723-ysyndromes, such as atrophy and cardiomyopathy [3]. In
clinical practice, treatment of these symptoms and diseases
involves reduction or stimulation of apoptosis, respectively.
Consequently, there is a strong need for methods that can
detect and quantify apoptosis on a microscopic level.
Currently, the standard methods of apoptosis detection in
tissue are histological or biochemical, which are time
consuming and require biopsies [4]. In vivo detection using
radionuclide imaging [5] and magnetic resonance imaging
[6] is currently under investigation.
Recently, Czarnota and co-workers reported that apoptosis
c o u l db ed e t e c t e db yh i g h - f r e q u e n c yu l t r a s o u n d[ 7]. They
observed an increase in backscattering of the ultrasound
signal, which they attributed to the disintegration of the
nucleus, a distinctive feature of apoptosis. Optical coherence
tomography (OCT) imaging, the optical and high-resolution
equivalent of ultrasound imaging, is based on time of flight-
dependent intensity differences of backscattered light [8]. In
a previous study we used OCT to image porcine carotid
arteries in ex vivo tissue culture [9]. We reported an increase
in backscattering in the medial layer after balloon dilation.
Since there is a rapid onset of apoptosis after balloon
angioplasty [10], we hypothesized that the changes in OCT
signal could be attributed to this characteristic form of cell
death. Functional OCT allows the quantitative measurement
of tissue absorption and scattering properties, at the
microscopic level. Because both apoptosis and necrosis
directly influence the cell’s main scatterers (i.e. nucleus,
membrane, mitochondria, and other cellular organelles [11–
16]), we hypothesized that the local optical attenuation
coefficient (µt), which describes the decay of measured
intensity against. depth, could be used to assess cell death.
Moreover, due to the differences in the morphology of the
two pathways of cell death, we hypothesized that differences
could be observed in the attenuation of light by necrotic and
apoptotic cells compared with that by normal cells and that
those changes could be monitored in time, after induction of
cell death. In this paper, we describe OCT measurements of
the optical attenuation coefficient of pelleted human fibro-
blasts, in which necrosis or apoptosis had been induced.
Materials and methods
Cells and reagents
Human fibroblasts were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) (Gibco/BRL) supplemented with
10% fetal calf serum, streptomycin at 100 µg/ml and
penicillin at 100 U/ml in a fully humidified atmosphere
containing 5% carbon dioxide (CO2) at 37°C. Prior to the
experiment, subconfluent grown cells were trypsinized and
collected by centrifugation at 500 g for 10 min. At time (t)=0,
the pelleted cells were resuspended in DMEM containing 10%
ethanol, to induce necrosis, or 200 µM cytosine arabinoside
(AraC, Sigma), to induce apoptosis, or 0.1 mg/ml colchicine
(CX,Sigma),toinducemitotic arrest.After30minincubation,
the cells were pelletedandimagedbyOCTfor6h.Ina second
setofexperimentsthedose-dependencyofapoptosisinduction
by AraC was studied. Culture flasks with subconfluent grown
cells were incubated with 50 µM, 100 µM or 200 µM AraC
for 2 h. The cells were trypsinized and collected by
centrifugation at 500 g for 10 min. Pelleted cells were
immersed in medium and imaged by OCT at 3 h, 6 h, 9 h,
12 h and 24 h after the induction of apoptosis. Between and
during measurements the cells were kept at 37°C.
Fig. 1 Schematic representation of the different stages of necrosis
(left) and apoptosis (right). The process of necrosis starts with
membrane defects, followed by karyolysis and enzyme release, due
to cell disintegration. Once apoptosis has been triggered in a normal
cell (top), the membrane will change, leading to surface protrusions.
The condensed nucleus fragments, which is followed by disintegration
of the whole cell into apoptotic bodies, containing remnants of the
nucleus and other cell components. Apoptotic bodies are cleared by
phagocytosis by macrophages or neighbouring cells, or they undergo
secondary necrosis
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At the end of the OCT experiment, samples of pelleted cells
were subjected to immunofluorescence analysis, using a
commercially available apoptosis detection kit (Sigma). The
double-labelling assay with annexin V-Cy3 (AnnV) and
6-carboxyfluorescein diacetate (CFDA) allows differentiation
between apoptotic, necrotic and viable cells. The CFDA is
processed in metabolically active cells into fluorescing
6-carboxyfluorescein (6-CF). The AnnV-Cy3 label binds to
phosphatidyl serine residues when they appear in the outer
leaflet of the cell membrane, which occurs in compromised
cells that are apoptotic or necrotic. Therefore, cells that are
labelled only with 6-CF (green) are viable cells, cells labelled
only with Ann-Cy3 (red) are necrotic cells, and cells stained
with both are apoptotic. The cells were labelled in
accordance with the manufacturer’si n s t r u c t i o n s .
Flow cytometry
To measure the necrotic and apoptotic fraction after induction
of cell death, we harvested cells at different time points and
washed them in ice-cold 4-(2-hydroxyethyl)-1-piperazine-
ethane-sulphonic acid (HEPES) buffer [10 mM HEPES,
150 mM potassium chloride (KCl), 1 mM magnesium
chloride (MgCl2) and 1.3 mM calcium chloride (CaCl2),
pH 7.4] supplemented with 1 mg/ml glucose and 0.5% (w/v)
bovine serum albumin (BSA). The cells were then incubated
with fluorescein isothiocyanate (FITC)-labelled annexin V
(diluted 1:200 in HEPES buffer) for 15 min and washed
again in HEPES buffer. Just before analysis of the samples
by flow cytometry (FACSCalibur, Becton Dickinson, San
Jose, CA, USA), propidium iodide (PI) was added (final
concentration 5 µg/ml) to distinguish necrotic cells
(annexin V−/PI+) from early apoptotic cells (annexin V+/
PI−) and late apoptotic cells (annexin V+/PI+) [4]. The
samples were analysed with a FACSCalibur (Becton Dick-
inson) instrument equipped with CellQuest software. The
cytometer was calibrated by eye with the fluorochrome
beads supplied by the manufacturer.
OCT imaging
The cells were imaged with a high-resolution time-
domain OCT setup in which a titanium (Ti):sapphire
laser (FemtoSource, Vienna, Austria), operating at a central
wavelength of 800 nm with a bandwidth of 125 nm, was used
as the light source. Depth scanning, by changing the length of
the (optical) path in the reference arm, was performed using a
so-called rapid-scanning optical delay (RSOD) line [17]i n
which a linear galvanometer was used. This allowed precise
and constant (speed and intensity) depth ranging at the
expense of reduced imaging speed. Moreover, it allowed
hardware-based compensation for the dispersion mismatch
between the reference arm and sample arm. In-depth
scanning was performed at 25 lines per second. For this
system, we measured a dynamic range of 110 dB and a free
space axial resolution of 5 µm. For each cell pellet and each
time point three to five b-scans were made.
Data analysis
In each b-scan, the attenuation coefficient (µt) of the pelleted
cells was obtained in a procedure described previously [18].
In short, the depth dependence of the amplitude of the OCT
signal can be described as the product of the axial point
spread function (PSF) of the optics used and the attenuation
of the light by the tissue structures [19–21]. An average
signal of 50–100 adjacent A-scans as a function of depth
was fitted to the model with µt as a fitting parameter,
incorporating both the known location of the focus in the
tissue and the previously measured depth of focus of the
imaging optics.
Results
In the experiments described in this study the cells were
pelleted and were proven to be viable (data not shown), as in
other studies [22–24]. Qualitatively, when compared with
untreated cells (Fig. 2a), the cells treated with 200 µM AraC
exhibited a temporary increase in OCT signal and a decrease
in imaging depth (Fig. 2b). In contrast, cells treated with
10% ethanol showed an increase in imaging depth (Fig. 2c).
These observations are quantified by the measurement of µt
of the samples in time as presented in Fig. 3. The AraC-
treated cells show an initial increase in µt,f o l l o w e db ya
decrease, ending up below the level of the control cells.
Treatment with 10% ethanol (EtOH) results in an immediate
decrease in backscatter, compared to untreated control cells.
As shown in the fluorescence images (Fig. 4), apoptosis
was induced in the AraC-treated cells. Panels 4a and 4b show
untreated control cells, and panels 4c and 4d show AraC-
treated cells. The green fluorescence (Fig. 4a, c) is a marker
for metabolically active cells (i.e. either viable or apoptotic
cells), whereas the red fluorescence marks the compromised
cells (i.e. necrotic or apoptotic cells). Therefore, the double-
labelled cells can be discerned between viable (green),
apoptotic (green and red), and necrotic (red) cells.
Since the necrotic process rapidly results in the clearance
of cells by rupture of the cell membranes, the EtOH- treated
cells were not visualized by fluorescence microscopy.
Fluorescence-activated cell sorter (FACS) analysis can
detect necrotic cells based on the scattering of remnants.
The result of the cell counting is presented in Fig. 5. The
decrease in average attenuation (dotted line) coincides with
Lasers Med Sci (2010) 25:259–267 261a decrease in viable cells (grey line) and a synchronous
increase in necrotic cells. No apoptotic cells were detected;
therefore, the decreasing total cell count has to be attributed
to the total clearance of necrotic cells.
The induction of apoptosis by AraC is known to be
dependent on the concentration. In Fig. 6 the results are
plotted of the attenuation measurement of cells treated with
50 µM (Fig. 6a), 100 µM (Fig. 6b), and 200 µM (Fig. 6c).
The higher the concentration of AraC, the earlier the rise in
attenuation is observed.
To study the effect of nuclear condensation on the
attenuation, we treated cells with colchicine (Fig. 7). The
resulting increase in µt mimicked the apoptosis curves.
Discussion
In the experiments described in this paper, an increase in µt
was observed in pelleted cells after treatment with AraC.
AraC is known to induce apoptosis via incorporation into
DNA during replication, acting as a chain terminator [25].
However, AraC can also induce apoptosis directly through
oxidative stress, with an increase in the generation of
reactive oxygen species and tumour suppressor protein 53
(p53)-dependent cytotoxicity [26, 27]. This latter, rapid,
pathway has been shown to induce apoptosis in lymphoid
cells within 3 hours [26]. Apart from its use in leukemia
treatment, its use is known to induce apoptosis in neuronal
cells [28] and fibroblasts [29].
Apoptosis was, indeed, detected with a commercially
available viability assay, combining 6-CDFA with an
annexin V-Cy3 label. Annexin V binds to the phosphatidyl
serine that is redistributed from the inner to the outer leaflet
of the plasma membrane as an early event in the apoptotic
programme [30]. Binding of annexin V to externalized
phosphatidyl serine has formed the basis for widely used
optical methods (fluorescence microscopy and flow cytom-
etry) for detecting apoptosis [4]. Furthermore, AraC is
known to induce apoptosis in a dose-dependent fashion [31,
32]. A similar dependency was observed in the changes in
µt in our experiments.
There is a great variety in apoptosis inducers [33]. In
an experimental setup similar to the one described here,
we induced apoptosis in mouse fibroblasts (MFs) with
staurosporine [33], and subjected human lung carcinoma cell
line (SW 1573) to 5-aminolaevulinic acid-photodynamic
therapy (ALA-PDT) [34]. The preliminary results indicated
t h a t ,i nb o t hc e l ll i n e s ,a ni n c r e a s ei nµ t was observed (data
not shown).
The origin of light scattering from cells is still the
subject of studies. Scattering occurs due to the mismatch in
indices of refraction between these different cellular
compartments and is also dependent on the size and shape
of the scatterer [11, 13, 35–37]. In the case of necrosis, the
cell and its organelles disintegrate, resulting in an amor-
phous mass. The decrease in scattering from necrotic cells
can, therefore, probably be explained by the removal of
potential scatterers. On the other hand, cellular swelling
prior to cell lysis might lead to an initial increase in
Fig. 3 The attenuation coefficient measured in pelleted human
fibroblasts, as a function of time. Time was measured in minutes
from the point that the cells were forced into necrosis (filled squares)
or apoptosis (filled dots). Sham-treated (control) cells show no change
in scattering (circles)
Fig. 2 Examples of
OCT images of pelleted cells.
Untreated control cells (a)
remained unchanged during the
entire experiment. Apoptotic
AraC-treated cells (b) showed
an increase in scattering in the
top layer, whereas necrosis (c)
resulted in a decrease in signal
262 Lasers Med Sci (2010) 25:259–267scattering, which was not observed in our experiments.
Valenzeno and Trank proposed a technique for measure-
ment of the blood haematocrit based on the decrease of
forward scattering during erythrocyte lysis. The loss of
refractive index mismatches reduced the scattering coeffi-
cient and anisotropy [38]. The degree of haemolysis is
inversely related to the intensity of small angle scattering.
Furthermore, in experiments monitoring the optical density
(OD) of cell suspensions, Kravtsov and Fabian reported a
clear decrease in OD after the induction of necrosis [12].
The apoptotic process involves a series of morphological
changes in which many potential scatterers are involved. It
has been reported that the initial increase in scattering could
be due to cellular shrinkage [14], to chromatin condensa-
tion [16], to nuclear fragmentation [13] or to mitochondrial
swelling [39] and release of cytochrome c [40]. In
investigations of mitochondrial morphology in apoptosis,
single-angle light-scattering data [41] and absorption
Fig. 5 After induction with 10% ethanol (t=0), the number of viable
cells (grey line, open dots) decreases and the number of necrotic cells
(black line, filled dots) increases. The total number of cells (grey
dotted line) decreases, due to loss of necrotic cells. The decrease in µt
(black dotted line) coincides with the increase in necrosis
Fig. 4 Images of immunofluo-
rescence labelling of control
cells (a, b) and cells treated with
200 mM AraC (c, d)a t2 4h .
When the green fluorescing
label CFDA (a, c) is used, viable
cells can be identified, whereas
the red fluorescing label AnnV
(b, d) is specific for apoptotic
cells. At 24 h, 5% of the control
cells have become apoptotic,
while, after treatment with
200 mM AraC, 61% of cells
are apoptotic
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changes in suspensions of viable mitochondria isolated
from apoptotic cells. Different results were obtained with
these techniques (see, e.g., Kroemer et al. [43]), with some
studies showing light scattering suggestive of mitochondrial
swelling [41], whereas others showed no change [42]. By
measuring the intensity ratio of wide-to-narrow angle
scatter in single cells during apoptosis researchers have
shown that the changes in the mitochondrial membrane
preceded the exposure to phosphatidyl serine [44].
Kravtsov and co-workers [12] designed an assay in
which they monitored the OD of cells in suspension. When
inducing apoptosis, they observed a temporary increase in
OD, comparable to the increase in µt in this study.
Morphological analysis of their samples revealed that the
increase in OD coincided with the blebbing of the apoptotic
cell membrane. The initial OD increase was followed by a
decrease when the majority of the cells had passed the
blebbing stage. If we consider the similarities with the
results presented here, especially the transient tendency of
the µt increase, it is likely that membrane blebbing is
responsible for the results of our study.
In flow cytometry apoptotic cells are also identified on
the basis of changes in scattering. Whereas this study
focused on backscattered light, cytometry registers for-
ward and side (90° angle) scattering of single cells. In
flow cytometry data analysis, the forward scatter signal is
correlated with the cell size, and the side scatter signal is
correlated with the cell’s refractive and reflective proper-
ties and reveals optical inhomogeneity, such as that
resulting from condensation of cytoplasm or nucleus and
granularity. During the apoptotic process, there is a slight
initial decrease in forward scatter (cell shrinkage and
mitochondrial swelling), followed by an increase in side
scatter (nuclear condensation and fragmentation). The
formation of apoptotic bodies is characterized by a
decrease in both forward and side scatter [45]. Accord-
ingly, changes in light scatter properties can contribute to
the rapid and easy identification of apoptotic cells in
particular conditions.
Fig. 7 Colchicine-treated cells (black dotted line) mimic the µt curve
of the AraC-treated cells (grey line). However, the maximum values of
µt are higher, and secondary necrosis is not significantly detected.
Untreated control cells are represented by the black line
Fig. 6 Dose-dependency curves of the increase in µt after treatment
with 50 µM (a), 100 µM (b), and 200 µM (c) AraC. The higher the
dose, the earlier is the onset of the µt increase. The black lines depict
the untreated control cells, and the dotted lines are AraC-treated
apoptotic cells
264 Lasers Med Sci (2010) 25:259–267Czarnota et al. used colchicine to image mitotic arrested
cells, which would be normal cells with a condensed
nucleus. Whereas the initial goal was to image cells with
mere condensed nuclei, possibly also apoptosis was
induced in the colchicine-treated cells. Unfortunately, under
certain experimental conditions, colchicine is also described
as an apoptosis inducer [46, 47].
Clinical implications and study limitations
The monitoring of apoptosis could play an important role in
the clinic [1]. Apart from an apparent diagnostic value,
online monitoring of apoptosis in response to treatment
could greatly improve therapeutic efficacy in, e.g., skin
cancer treatment.
Apoptosis also plays a role in cardiovascular disease.
Apoptosis of vascular smooth muscle cells [48, 49] and
macrophages [50] localizes in so-called vulnerable lesions,
i.e. those lesions most likely to rupture, and at sites of
actual ruptured plaques. In in vivo studies, induction of
apoptosis in endothelial cells as well as in smooth muscle
cells has been shown to result in thrombosis [51] and
plaque rupture [52], respectively. However, before OCT can
be used to detect vascular apoptosis, the specificity and
sensitivity of the detection of cell death has to be
investigated.
Although the loss of cell integrity during necrosis could
be determined by flow cytometry, the identification of
apoptosis in fibroblasts met with insurmountable difficul-
ties. Flow cytometry was developed for the analysis of
single cells that grow in suspension. Adherent cells, like
the fibroblasts used in this study, are very difficult to
analyse by cytometry due to clumping of the cells, and
rupturing of cells when resuspending. Furthermore, it
should be stressed that, because the cells become detached
during late stages of apoptosis, many apoptotic cells may
be selectively lost if the analysis is limited to the attached
cells only [53].
Further research has to be done to elucidate the origin of
light scattering by cells in order to address the question of
the reason of rapid light scattering changes in dying cells,
especially compared to the later observed apoptosis by
biochemical methods. Chalut et al. showed that within 1.5
hours of apoptosis induction, the sub-cellular organization,
described as the fractal dimension, rapidly decreases [54].
They also observed a biphasic response in time, which was
possibly related to mitochondrial swelling, fission and
fusion. Similarly, Mulvey et al. recently described rapid
changes in scattering of suspensions of cells after induction
of apoptosis [55]. Because the index of refraction of
membranes is relatively high (~1.46) [56], changes in the
membrane structure may have a relatively large effect on the
scattering properties. Furthermore, the effect of dependent
scattering, e.g. due to the packing of scatterers, may also
influence the measurement of optical properties [57].
It remains to be defined whether the changes in light
scatter properties are characteristic of apoptosis or whether
they correspond to general features of cell death, whatever
the mode of cell death considered. Conversely, OCT
measurements as described in this study could be helpful
in identifying the scatterers in cells, but other techniques
based on elastic light scattering [58–60] or combined with
Raman spectroscopy [61] may also be suitable.
Conclusion
The results from the cultured cells described in this study
indicate the ability of OCT to detect and differentiate
between viable, apoptotic and necrotic cells, based on their
optical properties. This functional supplement to high-
resolution OCT imaging can be of great clinical benefit,
enabling the on-line monitoring of tissues or for feedback in
cancer treatment. Furthermore, OCT imaging of apoptosis
in the vascular wall might enhance the ability of OCT to
detect the vulnerable plaque.
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